bluebird bio
BLUE
#9803
Rank
โ‚น4.37 B
Marketcap
โ‚น446.49
Share price
0.00%
Change (1 day)
-74.15%
Change (1 year)

Earnings for bluebird bio (BLUE)

Earnings in 2025 (TTM): -โ‚น16.82 Billion

According to bluebird bio 's latest financial reports the company's current earnings are โ‚น0.10 Billion. In 2024 the company made an earning of -โ‚น21.62 Billion a decrease over its 2023 earnings that were of -โ‚น19.74 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for bluebird bio from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น16.82 Billion-22.22%
2024 -โ‚น21.62 Billion9.52%
2023 -โ‚น19.74 Billion-17.54%
2022 -โ‚น23.94 Billion-18.85%
2021 -โ‚น29.5 Billion-46.87%
2020 -โ‚น55.52 Billion-21.79%
2019 -โ‚น70.99 Billion42.26%
2018 -โ‚น49.9 Billion65.59%
2017 -โ‚น30.14 Billion27%
2016 -โ‚น23.73 Billion58.42%
2015 -โ‚น14.98 Billion175.54%
2014 -โ‚น5.44 Billion138.96%
2013 -โ‚น2.28 Billion6.98%
2012 -โ‚น2.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น61.02 B-439.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚น22.96 Billion 27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น817.53 B-4,654.41%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-โ‚น9.8 Billion-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.074 T-11,655.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.65 Billion-85.24%๐Ÿ‡บ๐Ÿ‡ธ USA